Last reviewed · How we verify
sintilimab combined with bevacizumab and XELOX
sintilimab combined with bevacizumab and XELOX is a Small molecule drug developed by xiaohua li. It is currently in Phase 2 development.
At a glance
| Generic name | sintilimab combined with bevacizumab and XELOX |
|---|---|
| Sponsor | xiaohua li |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer (PHASE3)
- Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer (PHASE2)
- To Explore the Efficacy of Sintilimab Combined with Bevacizumab in Rectal Cancer (PHASE2)
- Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in PMMR/MSS CRLM Patients (PHASE1, PHASE2)
- Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- sintilimab combined with bevacizumab and XELOX CI brief — competitive landscape report
- sintilimab combined with bevacizumab and XELOX updates RSS · CI watch RSS
- xiaohua li portfolio CI
Frequently asked questions about sintilimab combined with bevacizumab and XELOX
What is sintilimab combined with bevacizumab and XELOX?
sintilimab combined with bevacizumab and XELOX is a Small molecule drug developed by xiaohua li.
Who makes sintilimab combined with bevacizumab and XELOX?
sintilimab combined with bevacizumab and XELOX is developed by xiaohua li (see full xiaohua li pipeline at /company/xiaohua-li).
What development phase is sintilimab combined with bevacizumab and XELOX in?
sintilimab combined with bevacizumab and XELOX is in Phase 2.